Alzamend Neuro
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$9,947,746 over the previous period. Total operating expenses were $9,937,645.
Profit Margin
| 2017 | 0 | -1.56M | |
|---|---|---|---|
| 2019 | 0 | -4.86M | |
| 2020 | 0 | -4.39M | |
| 2021 | 0 | -5.20M | |
| 2022 | 0 | -12.40M | |
| 2023 | 0 | -14.87M | |
| 2024 | 0 | -9.94M |
ALZN Income Statement (2017 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 50.74K | 23.06K | 0 | 0 | 0 | 0 | 0 |
Gross profit | -50.74K | -23.06K | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 6.45M | 7.44M | 5.20M | 1.31M | 1.06M | 3.70M | 275.04K |
Selling and marketing | 247.33K | 742.60K | 17.65K | 0 | 0 | 0 | 330.83K |
Total operating expenses | 9.93M | 14.87M | 12.31M | 4.95M | 4.42M | 5.00M | 1.54M |
Operating income | -9.93M | -14.87M | -12.31M | -4.95M | -4.42M | -5.00M | -1.54M |
Other income (expenses), net | -10.10K | -7.70K | -42.52K | -94.67K | 13.92K | 146.38K | -21.50K |
Income before tax | -9.94M | -14.87M | -12.36M | -5.04M | -4.41M | -4.86M | -1.56M |
Income tax expense | 0 | -144.82K | 42.52K | 157.09K | -13.92K | -146.38K | -21.50K |
Net income | -9.94M | -14.87M | -12.40M | -5.20M | -4.39M | -4.86M | -1.56M |
Earnings per share | |||||||
Basic EPS | -14.72 | -22.89 | -2.09 | -1.07 | -9.26 | -0.86 | -8.18 |
Diluted EPS | -14.7 | -22.89 | -2.09 | -1.07 | -9.25 | -0.86 | -8.18 |
| Data source | Data source | Data source | Data source |